Interferon-γ in autoimmunity

Cytokine and Growth Factor Reviews

Volumn 7, Issue 1, 1996, Pages 25-34

  Billiau, Alfons ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Autoimmunity; IFN ; Inflammatory reaction

Indexed keywords

CYTOKINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ARTHRITIS; AUTOIMMUNITY; ETIOLOGY; EXPERIMENTAL MODEL; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; RAT; SHORT SURVEY;

EID: 0030183108     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/1359-6101(96)00004-4     Document Type: Short Survey

References (106)

1. 1. Young HA, Hardy KJ. Role of interferon-gamma in immune cell regulation. J Leukocyte Biol 1995, 58, 373-381.
2. 2. Dustin ML, Rothlein R, Bhan AK, Dinarello CE, Springer TA. Tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). Induction by IL-1α and interferon-γ. J Immunol 1993, 137, 245-254.
3. 3. McCarron RM, Wang L, Racke MK, McFarlin DE, Spatz M. Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J Neuroimmunol 1993, 43, 23-30.
4. 4. Yu CL, Haskard DO, Cavender D, Johnson A, Ziff M. Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol 1985, 62, 554-560.
5. 5. Male D, Rahman J, Linke A, Zhao W, Hickey W. An interferon-inducible molecule on brain endothelium which controls lymphocyte adhesion mediated by integrins. Immunology 1995, 84, 453-460.
6. 6. Huynh HK, Dorovini-Zis K. Effects of interferon-γ on primary cultures of human brain microvessel endothelial cells. Am J Pathol 1993, 142, 1265-1278.
7. 7. Marfaing-Koka A, Devergne O, Gorgone G, et al. Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13. J Immunol 1995, 154, 1870-1878.
8. 8. Landolfo S, Gariglio M, Gribaudo G, Jemma C, Giovarelli M, Cavallo G. Interferon-γ is not an antiviral, but a growth-promoting factor for T lymphocytes. Eur J Immunol 1988, 18, 503-509.
9. 9. Fernandez-Botran R, Sanders VM, Mosmann TR, Vitetta ES. Lymphokine-mediated regulation of the proliferative response of clones of T helpers 1 and T helpers 2 cells. J Exp Med 1988, 168, 543-558.
10. 10. Gajewski TF, Fitch FW. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 1988, 140, 4252.
11. 11. Pernis A, Gupta, Gollob KJ, et al. Lack of interferon γ receptor β chain and the prevention of interferon γ signalling in TH 1 cells. Science 1995, 269, 245-247.
12. 12. Liu Y, Janeway CAJ. Interferon γ plays a critical role in induced cell death of effector T cells: a possible third mechanism of self-tolerance. J Exp Med 1990, 172, 1735-1739.
13. 13. Novelli F, Di Pierro F, Di Celle PF. et al. Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis. J Immunol 1994, 152, 496-504.
14. 14. Matthys P, Froyen G, Huang S, et al. Interferon-γ receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis: protective role of endogenous nitric oxide. J Immunol 1995, 155, 3823-3829.
15. 15. Sarvetnick N, Shizuru J, Liggitt L, et al. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature 1990, 346, 844-847.
16. 16. Lee M-S, Von Herrath M, Reiser H, Oldstone MBA, Sarvetnick N. Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. J Clin Invest 1995, 95, 486-492.
17. 17. Siegel JP. Effects on interferon-γ on the activation of human T lymphocytes. Cell Immunol 1988, 111, 461-472.
18. 18. Landolfo S, Cofano F, Giovarelli M, Prat M, Cavallo G, Forni G. Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo. Science 1985, 229, 176-179.
19. 19. Simon MM, Hochgeschwender U, Brugger U, Landolfo S. Monoclonal antibodies to interferon-γ inhibit interleukin 2-dependent induction growth and maturation to lectin/antigen-reactive cytolytic lymphocyte precursors. J Immunol 1986, 136, 2755-2762.
20. 20. Bucy P, Hanto DW, Berens E, Schreiber RD. Lack of an obligate role for IFN-γ in the primary in vitro mixed lymphocyte response. J Immunol 1988, 140, 1148-1152.
21. 21. Abed NA, Chace JH, Fleming AL, Cowdery JS. Interferon-γ regulation of B lymphocyte differentiation: activation of B cells is a prerequisite for IFN-γ-mediated inhibition of B cell differentiation. Cell Immunol 1994, 153, 356-366.
22. 22. Abed NS, Chace JH, Cowdery JS. T cell-independent and T cell-dependent B cell activation increases IFN-gamma R expression and renders B cells sensitive to IFN-gamma-mediated inhibition. J Immunol 1994, 153, 3369-3377.
23. 23. Garvy BA, Riley RL. IFN-gamma abrogates IL-7-dependent proliferation in pre-B cells, coinciding with onset of apoptosis. J Immunol 1994, 81, 381-388.
24. 24. Grawunder U, Melchers F, Rolink A. Interferon-γ arrests proliferation and causes apoptosis in stromal cell interleukin-7-dependent normal murine pre-B cell lines and clones in vitro, but does not induce differentiation to surface immunoglobulin-positive B cells. Eur J Immunol 1993, 23, 544-551.
25. 25. Trubiani O, Bosco D, Di Primio R. Interferon-gamma (IFN-gamma) induces programmed cell death in differentiated human leukaemic B cell lines. Exp Cell Res 1994, 215, 23-27.
26. 26. Buschle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK. Interferon γ inhibits apototic cell death in B cell chronic lymphocytic leukaemia. J Exp Immunol 1993, 177, 213-218.
27. 27. Billiau A, Matthys P. Interferon-γ, more of a cachectin than tumor necrosis factor. Cytokine 1992, 4, 259-263.
28. 28. Matthys P, Heremans H, Opdenakker G, Billiau A. Anti-interferon-γ-antibody treatment, growth of Lewis lung tumors in mice and tumor-associated cachexia. Eur J Cancer 1991, 27, 182-187.
29. 29. Langstein HN, Doherty GM, Fraker DL, Buresh CM, Norton JA. The roles of γ-interferon and tumor necrosis factor α in an experimental rat model of cancer cachexia. Cancer Res 1991, 51, 2302-2306.
30. 30. Matthys P, Dijkmans R, Proost P, et al. Severe cachexia in mice inoculated with interferon-γ-producing tumor cells. Int J Cancer 1991, 49, 77-82.
31. 31. Wall DA, Hamberg SD, Burakoff SJ, Reynolds DS, Abbas AK, Ferrara LM. Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression. J Immunol 1988, 140, 2970-2976.
32. 32. Hutchet R, Bruley-Rosset M, Mathiot C, Grandjon D, Halle-Pannenko O. Involvement of IFN-gamma and transforming growth factor-β in graft-vs-host reaction-associated immunosuppression. J Immunol 1993, 150, 2517-2524.
33. 33. Ishikura H, Jayaraman S, Kuchroo V, Diamond B, Saito S, Dorf ME. Functional analysis of cloned macrophage hybridomas. J Immunol 1989, 143, 414-419.
34. 34. Noma T, Dorf ME. Modulation of suppressor T cell induction with γ-interferon. J Immunol 1985, 135, 3655-3660.
35. 35. Gosselin D, Turcotte R, Lemieux S. Cellular target of in vitro-induced suppressor cells derived from the spleen of Mycobacterium lepraemurium-infected mice and role of IFN-γ in their development. J Leukocyte Biol 1995, 57, 122-128.
36. 36. Tomioka H, Sato K, Maw WW, Saito H. The role of tumor necrosis factor, interferon-γ, transforming growth factor β, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection. J Leukocyte Biol 1995, 58, 704-712.
37. 37. Sileghem M, Hamers R, De Baetselier P. Experimental Trypunsoma brucei infections selectively suppress both interleukin-2 production and interleukin-2 receptor expression. Eur J Imnnmol 1987, 17, 1417-1421.
38. 38. Darji A, Sileghem M, Heremans H. Brys L, Billiau A, De Baetselier P. Immunosuppression of T cell responsiveness during experimental murine Trypanosoma brucei infections: active participation of endogenous interferon-gamma. Infect Immun 1993, 61, 3098-3102.
39. 39. Metzger Z, Hoffeld JT, Oppenheim JJ. Macrophage-mediated suppression. I. Evidence for participation of both hydrogen peroxide and prostaglandin in suppression of murine lymphocyte proliferation. J Immunol 1980, 124, 983-988.
40. 40. Boraschi D, Censini S, Tagliabue A. Interferon-γ reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production. J Immunol 1984, 133, 764-768.
41. 41. Albina JE, Abate JA, Henry WLJ. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-γ in the induction of nitric oxide-synthesizing pathway. J Immunol 1991, 147, 144-148.
42. 42. Mills CD. Molecular basis of suppressor macrophages. Arginine metabolism via the nitric oxide sythetase pathway. J Immunol 1991, 146, 2719-2723.
43. 43. Twardzik DR, Mikovits JA, Ranchalis JE, Purchio AF, Ellingsworth L, Ruscetti FW. c-Interferon-induced activation of latent transforming growth-factor-β by human monocytes. Ann NY Acad Sci 1990, 593, 276-284.
44. 44. Taborski U, Freitag W, Heremans H, Knop J. Inhibitory effects of interferon-γ on the suppressor cell circuit in contact sensitivity. Immunobiology 1986, 171, 329-338.
45. 45. Frasca D, Adorini L, Landolfo S, Doria G. Enhancement of suppressor T cell activity by injection of anti-IFN-γ monoclonal antibody. J Immunol 1988, 140, 4103-4107.
46. 46. Kawakami Y, Kuzuya N, Watanabe T, Uchiyama Y, Yamashita K. Induction of experimental thyroiditis in mice by recombinant interferon γ administration. Acta Endocr 1990, 122, 41-48.
47. 47. Tang H, Mignon-Godefrey K, Meroni PE, Garotta G, Charriere J, Nicoletti F. The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells. Eur J Immunol 1993, 23, 275-278.
48. 48. Campbell IL, Kay TWH, Oxbrow L, Harrison LC. Essential role of interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 1991, 87, 739-742.
49. 49. Hartung H-P, Schäfer B, Van der Meide PH, Fierz W, Heininger K, Toyka KV. The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neurol 1990, 27, 247-257.
50. 50. Strigard K, Holmdahl R, Van de Meide PH, Klareskog E, Olsson T. In vivo treatment of rats with monoclonal antibodies against gamma interferon: effects on experimental allergic neuritis. Acta Neurol Scand 1989, 80, 201-207.
51. 51. Campbell IL, Oxbrow L, Koulmanda M, Harrison LC. IFN-;γ induces islet MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. J Immunol 1988, 140, 1111-1116.
52. 52. Pujol-Borrell R, Todd I, Doshi M, et al. HLA Class II induction in human islet cells by interferon-γ plus tumor necrosis factor or lymphotoxin. Nature 1987, 326, 304-306.
53. 53. Debraye-Sachs M, Carnaud C, Boitard C, et al. Prevention of diabetes in NOD mice treated with antibody to murine IFN-γ. J Autoimmun 1991, 4, 237-248.
54. 54. Kay TWH, Campbell IL, Oxbrow L, Harrison LC. Over-expression of Class I major histocompatibilily complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-γ antibody. Diabetologia 1991, 34, 779-785.
55. 55. Campbell IL, Oxbrow L, Harrison LC. Reduction in insulitis following administration of IFN-γ and TNF-α in the NOD mouse. J Autoimmun 1991. 4, 249-262.
56. 56. Gu D, Sarvetnick N. Epithelial cell proliferation and islet neogenesis in IFN-γ transgenic mice. Development 1993, 118, 33-46.
57. 57. Wogensen L, Molony L, Gu D, Krahl T, Zhu S, Sarvetnick N. Postnatal anti-interferon-γ treatment prevents pancreatic inflammation in transgenic mice with β-cell expression of interferon-γ. J Interferon Res 1994, 14, 111-116.
58. 58. Lee M-S, Sarvetnick N. Induction of vascular addressins and adhesion molecules in the pancreas of IFN-gamma transgenic mice. J Immunol 1994, 152, 4597-4603.
59. 59. Yamada K, Otabe S, Inada C, Takane N, Nonaka K. Nitric oxide and nitric oxide synthase mRNA induction in mouse islet cells by interferon-γ plus tumor necrosis factor-α. Biochem Biophys Res Commun 1993, 197, 22-27.
60. 60. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Ann Rev Immunol 1990, 8, 579-621.
61. 61. Aharoni R, Teitelbaum D, Arnon R. T suppressor hybridomas and interleukin-2-dependent lines induced by copolymer 1 or by spinal cord homogenate down-regulate experimental allergic encephalomyelitis. Eur J Immunol 1993, 23, 17-25.
62. 62. Teitelbaum D, Meshorer A, Hirschfield T, Arnon R, Sela M. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. Eur J Immunol 1971, 1, 242-248.
63. 63. Gaur A, Wiers B, Liu A, Rothbard J, Fathman GC. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 1992, 258, 1491-1494.
64. 64. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992, 149, 2496-2505.
65. 65. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential up-regulation of transforming growth factor β. interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992, 176, 1355-1364.
66. 66. Merrill JE, Kono DH, Clayton J, Ando DG, Hinton DR, Hofman FM. Inflammatory lymphocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL/J and B10.PL mice. Proc Natl Acad Sci USA 1992, 89, 574-578.
67. 67. Renno T, Lin J-Y, Piccirillo C, Antel J, Owens T. Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. J Neuroimmunol 1994, 49, 1-7.
68. 68. Rott O, Fleischer B, Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 1994, 24, 1434-1440.
69. 69. McDonald AH, Swanborg RH. Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis. J Immunol 1988, 140, 1132-1138.
70. 70. Ofosu-Appiah W, Mokhatarian F. Characterization of a T suppressor cell line that down-grades experimental allergic encephalomyelitis in mice. Cell Immunol 1991, 135, 143-153.
71. 71. Killen JA, Swanborg RH. Regulation of experimental allergic encephalomyelitis. Part 4; further characterization of post-recovery suppressor cells. J Neuroimmunol 1982, 3, 159-166.
72. 72. Wekerle H, Lassmann H. Contra-evidence against a primary lesion in the target organ in autoimmune disease. Int Arch Allergy Immunol 1994, 103, 328-331.
73. 73. Wekerle H. Experimental autoimmune encephalomyelitis as a model of immune-mediated CNS disease. Curr Opin Neurobiol 1993, 3, 779-784.
74. 74. Olsson T, Diener P, Ljungdahl A, Höjeberg B, Van der Miede PH, Kristensson K. Facial nerve transection causes expansion of myelin autoreactive T cells in regional lymph nodes and T cell homing to the facial nucleus. Autoimmunity 1992, 13, 117-126.
75. 75. Maehlen J, Olsson T, Zachau A, Klareskog L, Kristensson K. Local enhancement of MHC Class I and II and cell infiltration in experimental allergic encephalomyelitis around axotomized motor neurons. J Neuroimmunol 1989, 23, 125-132.
76. 76. Neumann H, Cavalie A, Jenne DE, Wekerle H. Induction of MHC Class I genes in neurons. Science 1995, 269, 549-552.
77. 77. Opdenakker G. Van Damme J. Cytokine-regulated proteases in autoimmune diseases. Immunol Today 1994, 15, 103-107.
78. 78. Schmied M, Breitschopf H, Gold R, Zischer H, Rothe G, Wekerle H. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 1993, 143, 446-452.
79. 79. Mustafa M, Diener P, Höjeberg B. Van der Miede P, Olsson T. T cell immunity and interferon-γ secretion during experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 1991, 31, 165-177.
80. 80. Vass K, Heininger K, Schäfer B, Linington C, Lassman H. Interleron-γ potentiates antibody-mediated demyelination in vivo. Ann Neurol 1992, 32, 198-206.
81. 81. Billiau A, Heremans H, Vandekerckhove F, et al. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 1988, 140, 1506-1510.
82. 82. Duong TT. St Louis J, Gilbert JJ, Finkleman FD, Strejan GH. Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J Neuroimmunol 1992, 36, 105-115.
83. 83. Caspi RR, Chan C-C, Grubbs BG, et al. Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice. J Immunol 1994, 152, 890-899.
84. 84. Voorthuis JAC, Uitdehaag BMJ, De Groot CJA, Goede PH, Van der Miede PH, Dijkstra CD. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in rats. Clin Exp Immunol 1190, 81, 183-188.
85. 85. Duong TT, Finkleman FD, Singh B, Strejan GH. Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J Neuroimmunol 1994, 53, 101-107.
86. 86. Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL, Tilton RG. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 1994, 93, 2684-2690.
87. 87. Ruuls SR, Van der Linden S, Huitinga I, Dijkstra CD. Immunosuppressive role for nitric oxide in experimental allergic encephalomyelitis. Nieuwsbrief Ned Verenig Immunol 1994, 94-4, 69 (Abstract).
88. 88. Woodroofe MN, Cuzner ML. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine 1993, 5, 583-588.
89. 89. Panitch HS, Haley AS, Hirsch RL, Johnson KP. Exacerbations of multiple sclerosis in patients with gamma interferon. Lancet 1987, i, 893-895.
90. 90. Panitch HS, Hirsch RL, Schindler J, Johnson KP. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987, 37, 1097-1102.
91. 91. Mauritz NJ, Holmdahl R, Jonsson R, Van der Miede PH, Scheynius A, Klareskog L. Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum 1988, 31, 1297-1304.
92. 92. Nakajima H, Takamori H, Hiyama Y, Tsukuda W. The effect of treatment with interferon-gamma on type II collagen-induced arthritis. Clin Exp Immunol 1990, 81, 441-445.
93. 93. Wahl SM, Allen JB, Ohura K, Chenoweth DE, Hand AR. IFN-γ inhibits inflammatory cell recruitment and the evolution of bacterial cell wall-induced arthritis. J Immunol 1991, 146, 95-100.
94. 94. Matthys P, Heremans H, Dillen C, Billiau A. Effects of interferon-γ and anti-interferon-γ antibodies on experimental arthritis in mice. J Interferon Res 1989, 9S, 130 (Abstract).
95. 95. Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Cytokines in chronic inflammatory arthritis - V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J Clin Invest 1990, 86, 1790-1798.
96. 96. Nakajima H, Hiyama Y, Tsukuda W, Warabi H, Uchida S, Hirose S. Effects of interferon gamma on cultured synovial cells from patients with rheumatoid arthritis: inhibition of cell growth, prostaglandin E2, and collagenase release. Ann Rheum Dis 1990, 49, 512-516.
97. 97. Ruschen S, Lemm G, Warnatz H. Spontaneous and LPS-stimulated production of intracellular IL-1β by synovial macrophages in rheumatoid arthritis is inhibited by IFN-γ. Clin Exp Immunol 1989, 76, 246-251.
98. 98. Andrews HJ, Bunning RAD, Dinarello CA, Russell RGG. Modulation of human chrondrocyte metabolism by recombinant human interferon-gamma: in vitro effects on basal and IL-1-stimulated proteinase production, cartilage degradation and DNA synthesis. Biochim Biophys Acta 1898, 1012, 128-134.
99. 99. Bunning RAD, Russell GG. The effect of tumor necrosis factor-α and γ-interferon on the resorption of human articular cartilage and on the production of prostaglandin E and of caseinase activity by human articular chrondrocytes. Arthritis Rheum 1989, 32, 780-784.
100. 100. Gowen M, Mundy GR. Action of recombinant interleukin-1, interleukin-2 and interferon-γ on bone resorption in vitro. J Immunol 1986, 136, 2478-2482.
101. 101. Takahashi N, Mundy G, Roodman GD. Recombinant human interferon-γ inhibits formation of human osteoclast-like cells. J Immunol 1986, 137, 3544-3549.
102. 102. Brok HPM, Heidt PJ, Van der Meide PH, Zurcher C, Vossen J. Interferon-γ prevents graft versus host disease after allogenic bone marrow transplantation in mice. J Immunol 1993, 151, 6451-6459.
103. 103. Cleveland MG, Annable CR, Klimpel GR. In vivo and in vitro production of IFN-β and IFN-γ during graft-vs-host disease. J Immunol 1988, 141, 3349-3356.
104. 104. Garside P, Reid S, Steel M, Mowat AM. Differential cytokine production associated with distinct phases of murine graft-versus-host reaction. Immunology 1994, 82, 211-214.
105. 105. Mowat AMI. Antibodies to IFN-γ prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology 1989, 68, 18-23.
106. 106. Donckier V, Abramowicz D, Bruyns C, et al. IFN-gamma prevents TH2 cell-mediated pathology after neonatal injection of semi-allogenic spleen cells in mice. J Immunol 1994, 153, 2361-2368.